EcoDrugPlus

Beta-Secretase 1

Ensembl ID : ENSOTSG00005024846
Gene Symbol: BACE1
1 Cross references
212 Possible Orthologues:

Beta-Secretase 1-Like

Ensembl ID : ENSOTSG00005020713
Gene Symbol: LOC112266844
3 Cross references
212 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSOTSG00005003984
Gene Symbol: BDKRB1
1 Cross references
144 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSOTSG00005003987
Gene Symbol: BDKRB2
1 Cross references
282 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSOTSG00005029226
Gene Symbol: BDKRB2
3 Cross references
148 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSOTSG00005006009
Gene Symbol: BDKRB2
3 Cross references
148 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSOTSG00005017959
Gene Symbol: BDKRB2
1 Cross references
277 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSOTSG00005009627
Gene Symbol: BDKRB2
1 Cross references
148 Possible Orthologues:

Breakpoint Cluster Region Protein-Like

Ensembl ID : ENSOTSG00005043010
Gene Symbol: LOC112263053
3 Cross references
190 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSOTSG00005047696
Gene Symbol: CALCRL
3 Cross references
141 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSOTSG00005011281
Gene Symbol: CALCRL
1 Cross references
141 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1d Subunit, A

Ensembl ID : ENSOTSG00005022242
Gene Symbol: CACNA1DA
1 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).